A population model for the follicular growth in women treated with follicle stimulating hormone

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 6, 1997, Pages 665-674

  Karlsson, Mats O ^a   Wade, Janet R ^b   Loumaye, Ernest ^c   Munafo, Alain ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; DRUG SAFETY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMMUNORADIOMETRIC ASSAY; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; POPULATION MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSVAGINAL ECHOGRAPHY;

ADULT; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; MENOTROPINS; MODELS, BIOLOGICAL; OVARIAN FOLLICLE; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0031426576     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90086-2     Document Type: Article

References (18)

1. Catt KJ, Dufau ML. Gonadatrophic hormones: biosynthesis, secretion, receptors and actions. In: Yen SSC, Jaffe RB, editors. Reproductive endocrinology. Philadelphia: WB Saunders; 1991. p. 105-55.
2. Jones HW Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, et al. The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14-21.
3. Loumaye E, Campbell R, Salat-Baroux J. Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum Reprod 1995;1:188-99.
4. Recombinant Human FSH Study Groups. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995;63: 77-86.
5. Porchet HC, le Cotonnec JY, Loumaye E. Clinical pharmacology of recombinant human follicle-stimulating hormone; III: pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration. Fertil Steril 1994;61:687-95.
6. Porchet HC, le Cotonnec JY. Pharmacokinetic and pharmacodynamic characteristics of recombinant human follicle-stimulating hormone. Assist Reprod Rev 1994;4:110-7.
7. Beal SL, Sheiner LB, editors. NONMEM users guides. San Francisco: NONMEM Project Group, University of California at San Francisco; 1992.
8. Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models; I: models for covariate effects. J Pharmacokinet Biopharm 1992;20:511-28.
9. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16: 31-41.
10. Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models. In: D'Argenio DZ, editor. Advanced methods of pharmacokinetic and pharmacodynamic systems analysis; vol 2. New York: Plenum Press; 1995. p. 69-86.
11. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-91.
12. Fuseau E, Sheiner LB. Simultaneous modeling of pharmacokinetics and pharmacodynamics with a non-parametric pharmacodynamic model. Clin Pharmacol Ther 1984;35:733-41.
13. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1993;21:457-78.
14. Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11.
15. Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-5.
16. Horvath PM, Styler M, Hammond JM. Shelden RM, Burford GD. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 1988;49:159-62.
17. Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, et al. The long term protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-4.
18. Acharya U, Small J, Randall J, Hamilton M, Templeton A. Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program. Fertil Steril 1992;57:815-8.